While several albumin fusions are currently in preclinical development or clinical trials, two have so far reached the market 7
Here's how they compare: Peptide Primary research area FDA status Advisory committee review BPC-157 Tissue repair, angiogenesis Not approved Yes (free base + acetate) TB-500 Actin regulation, cell migration Not approved Yes MOTS-c Mitochondrial metabolism Not approved Yes KPV Anti-inflammatory Not approved Yes GHK-Cu Copper-peptide skin/healing Not approved Not on 2026 agenda For a deeper comparison of BPC-157 and its most-researched counterpart, see our BPC-157 vs TB-500 research comparison
IRN, intermediate reticular nucleus
As a result, people often experience weight loss and difficulty gaining or maintaining weight, even when eating more
Who Can Benefit from IV Therapy
This process promotes the use of stored fat as fuel, allowing for more efficient calorie burning, especially during training